Alector, Inc. ALEC NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

42/100

3/7 Pass

SharesGrow Intrinsic Value

Ha habido 50 transacciones internas recientes registradas para Alector, Inc. (ALEC), incluyendo 20 compras y 28 ventas. El total de compras internas fue valorado en $1.23M y el total de ventas internas en $1.32M.

Internos destacados con actividad reciente incluyen Berkley Neil Lindsay, Rosenthal Arnon, Wong-sarad Grace. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.

Operaciones de Insiders — ALEC

Fecha	Nombre	Cargo	Tipo de Transacción	Acciones	Precio Promedio	Valor	Acciones en Propiedad
2026-03-15	Berkley Neil Lindsay	CFO & Chief Business Officer	Concesión de RSU	54,600	-	-	399,260
2026-03-13	Rosenthal Arnon	Chief Executive Officer	Concesión de RSU	116,246	-	-	2,454,422
2026-03-10	Wong-sarad Grace	Principal Accounting Officer	Venta Informativa	1,000	$2.65	$2.65K	106,465
2026-03-03	Wong-sarad Grace	Principal Accounting Officer	Venta Informativa	3,367	$2.08	$7.01K	107,465
2026-03-02	Rosenthal Arnon	Chief Executive Officer	Venta Informativa	81,864	$2.12	$173.82K	2,338,176
2026-03-02	Wong-sarad Grace	Principal Accounting Officer	Venta Informativa	8,071	$2.12	$17.14K	110,832
2026-03-02	Berkley Neil Lindsay	CFO & Chief Business Officer	Venta Informativa	29,649	$2.12	$62.95K	344,660
2026-02-26	Wong-sarad Grace	Principal Accounting Officer	Venta Informativa	4,079	$2.50	$10.2K	118,903
2025-12-05	Wong-sarad Grace	Principal Accounting Officer	Venta Informativa	4,753	$1.21	$5.75K	122,982
2025-12-03	Rosenthal Arnon	Chief Executive Officer	Venta Informativa	104,347	$1.12	$116.83K	2,420,040
2025-12-03	Kenkare-mitra Sara	President and Head of R&d	Venta Informativa	41,687	$1.12	$46.67K	501,652
2025-12-03	Wong-sarad Grace	Principal Accounting Officer	Venta Informativa	8,056	$1.12	$9.02K	127,735
2025-12-03	Berkley Neil Lindsay	Chief Bus Ofcr & Interim CFO	Venta Informativa	37,261	$1.12	$41.72K	374,309
2025-11-10	Rosenthal Arnon	Chief Executive Officer	Concesión de RSU	522,500	$1.31	$684.48K	522,500
2025-11-10	Wong-sarad Grace	Principal Accounting Officer	Concesión de RSU	48,535	$1.31	$63.58K	48,535
2025-11-10	Berkley Neil Lindsay	Chief Bus Ofcr & Interim CFO	Concesión de RSU	195,000	$1.31	$255.45K	195,000
2025-09-02	Rosenthal Arnon	Chief Executive Officer	Venta Informativa	51,562	$2.50	$128.74K	2,350,220
2025-09-02	Kenkare-mitra Sara	President and Head of R&d	Venta Informativa	23,638	$2.50	$59.02K	543,339
2025-09-02	Wong-sarad Grace	Principal Accounting Officer	Venta Informativa	5,910	$2.50	$14.76K	103,448
2025-09-02	Berkley Neil Lindsay	Principal Financial Officer	Venta Informativa	15,842	$2.50	$39.55K	346,570
2025-08-26	Hammond Paula	Director	Venta Informativa	14,000	$2.36	$33K	74,909
2025-07-01	Rosenthal Arnon	Chief Executive Officer	Concesión de RSU	45,700	$1.42	$64.89K	45,700
2025-07-01	Kenkare-mitra Sara	President and Head of R&d	Concesión de RSU	18,250	$1.42	$25.92K	18,250
2025-07-01	Berkley Neil Lindsay	Principal Financial Officer	Concesión de RSU	18,000	$1.42	$25.56K	18,000
2025-06-20	Yaffe Kristine	Director	Venta Informativa	1,000	$1.44	$1.44K	95,409
2025-06-20	Wong-sarad Grace	Principal Accounting Officer	Desconocido	11,552	$23.70	$273.78K	-
2025-06-20	Berkley Neil Lindsay	Principal Financial Officer	Desconocido	12,975	$1.11	$14.34K	-
2025-06-11	Desouza Errol B	Director	Concesión de RSU	9,450	$1.63	$15.4K	9,450
2025-06-11	Lavigne Louis J Jr	Director	Concesión de RSU	9,450	$1.63	$15.4K	9,450
2025-06-11	Scheller Richard H	Director	Concesión de RSU	9,450	$1.63	$15.4K	9,450
2025-06-11	Altmeyer Mark	Director	Concesión de RSU	9,450	$1.63	$15.4K	9,450
2025-06-11	Yaffe Kristine	Director	Concesión de RSU	9,450	$1.63	$15.4K	9,450
2025-06-11	Hammond Paula	Director	Concesión de RSU	9,450	$1.63	$15.4K	9,450
2025-06-11	Garofalo Elizabeth A.	Director	Concesión de RSU	9,450	$1.63	$15.4K	9,450
2025-06-02	Grasso Marc	Chief Financial Officer	Venta Informativa	16,488	$1.34	$22.07K	296,072
2025-06-02	Rosenthal Arnon	Chief Executive Officer	Venta Informativa	52,087	$1.34	$69.71K	2,414,657
2025-06-02	Kenkare-mitra Sara	President and Head of R&d	Venta Informativa	23,890	$1.34	$31.97K	512,252
2025-05-02	Scheller Richard H	Director	Concesión de RSU	15,833	-	-	66,666
2025-03-03	Grasso Marc	Chief Financial Officer	Venta Informativa	18,091	$1.47	$26.55K	312,560
2025-03-03	Rosenthal Arnon	Chief Executive Officer	Venta Informativa	40,330	$1.47	$59.18K	2,466,744
2025-03-03	Romano Gary	Chief Medical Officer	Venta Informativa	16,306	$1.47	$23.93K	332,977
2025-03-03	Kenkare-mitra Sara	President and Head of R&d	Venta Informativa	29,073	$1.47	$42.66K	536,142
2024-12-02	Grasso Marc	Chief Financial Officer	Venta Informativa	16,489	$2.52	$41.54K	330,651
2024-12-02	Rosenthal Arnon	Chief Executive Officer	Venta Informativa	52,172	$2.52	$131.44K	2,507,074
2024-12-02	Romano Gary	Chief Medical Officer	Venta Informativa	14,892	$2.52	$37.52K	349,283
2024-12-02	Kenkare-mitra Sara	President and Head of R&d	Venta Informativa	26,500	$2.52	$66.76K	565,215
2024-10-01	Grasso Marc	Chief Financial Officer	Concesión de RSU	216,400	-	-	347,140
2024-10-01	Rosenthal Arnon	Chief Executive Officer	Concesión de RSU	610,500	-	-	2,559,246
2024-10-01	Romano Gary	Chief Medical Officer	Concesión de RSU	184,380	-	-	364,175
2024-10-01	Kenkare-mitra Sara	President and Head of R&d	Concesión de RSU	300,000	-	-	591,715

■ Informativa — transacción en mercado abierto (más significativa) ■ No informativa (compra) — premio, ejercicio de opción, conversión ■ No informativa (venta) — retención fiscal, venta de adjudicación ■ Neutral — regalo, fideicomiso, vencimiento